Epidemiological surveillance estimates high bluetongue virus seroprevalence in cattle and sheep, indicating exposure post-epidemic.
To monitor the epidemiological situation of bluetongue virus (BTV) in Belgium, a national surveillance programme was conducted during the 2024–2025 winter season. The objective was to estimate the apparent seroprevalence of BTV-3 following the 2023–2024 epidemic and to prove the absence of active circulation of other BTV serotypes in mixed herds (cattle and sheep). A total of 2551 cattle and 1458 sheep were sampled across Belgium. Serological analyses were performed using ELISA, and molecular detection of BTV-3, BTV-8, and BTV-12 was conducted by RT-qPCR. The majority of cattle and sheep herds showed evidence of exposure to BTV-3, with a very high herd-level apparent seroprevalence (100%; 95% CI: 96.2–100% in cattle and 98.9%; 95% CI: 93.8–99.8% in sheep). Apparent within-herd seroprevalence was also high in cattle (94.6%; 95% CI: 91.8–96.5%) and sheep (85.5%; 95% CI: 80.4–89.5%). No evidence of active circulation of BTV-8 or BTV-12 was detected. A moderate significant positive correlation between Ct values and sampling date was observed both for bovine and ovine samples, consistent with a progressive decline in detectable BTV RNA during winter in the absence of vector activity.
No takes yet. Share an insight, caveat, or question.
Cargnel et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: